Baghdadi et al. showed that DAMPs released from chemotherapy-damaged tumor cells upregulate T cell immunoglobulin and mucin domain-containing molecule-4 (TIM-4) on tumor-associated myeloid cells, leading to the repression of tumor-specific immunity [197]. Here, TIMD4 is linked to neoplasm.